FDA Adverse Event Injury Summary report: N

ACCURUS 200

MDR report key: 1040276 · Received May 8, 2008

Report

Report Number
2028159-2008-00160
Event Type
Injury
Date Received
May 8, 2008
Date of Event
March 10, 2008
Report Date
April 7, 2008
Manufacturer
ALCON - IRVINE TECHNOLOGY CENTER
Product Code
HQC
PMA / PMN Number
K911808
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEPARTMENT OF OPHTHALMOLOGY'S REPORT FOR "POSTOPERATIVE ENDOPHTHALMITIS, A GUIDE TO DIAGNOSIS & TREATMENT" AND QUESTIONS TO DETERMINE IF CLEANING AND DIRECTIONS FOR USE INFO WERE ADDRESSED WITH THE FACILITY, BUT NO RESPONSE WAS NOTED. THE SURGEON SUSPECTS OTHER INSTRUMENTS IN THE OCCURRENCE OF THESE INFECTIONS. THE ROOT CAUSE OF THE REPORTED CASE OF ENDOPHTHALMITIS CANNOT BE DETERMINED IN THIS INVESTIGATION. THERE IS ONE ADDITIONAL COMPLAINT RELATED TO THE REPORTED EVENT AND IT IS FROM THE SAME FACILITY, THE SAME CONSOLE, BUT A DIFFERENT PT. A REVIEW OF COMPLAINT TREND INDICATES NO ADVERSE TRENDS FOR THE REPORTED COMPLAINT. ADDITIONAL INFO RECEIVED STATED THE SYSTEM IS STILL USED WITHOUT PROBLEM. NO OTHER CASE OF ENDOPHTHALMITIS HAS BEEN REPORTED. ALL THE FACILITY'S PROCEDURES REGARDING THE CLEANING AND THE STERILIZATION HAVE BEEN REVIEWED BUT NOTHING WAS FOUND OUT OF COMPLIANCE. THIS REPORT MAILED IN TO FDA ON: 05/07/2008.

Description of Event or Problem · 1

THE CUSTOMER REPORTED, TWO CASES OF ENDOPHTHALMITIS. THIS PT WAS DIAGNOSED THREE WEEKS POST-OP. THE PT WAS HOSPITALIZED FOR 9 DAYS. THE SURGEON COMPLETED A DOUBLE DISINFECTION WITH BETADINE (PROVIDONE-IODINE) ON THE EYE, EYELIDS AND FORNIX FOR TWO (2) TO THREE (3) MINUTES PRIOR TO SURGERY. DURING THE INITIAL SURGERY, A 3.2 MM TEMPORAL INCISION WAS COMPLETED. THE INCISION WAS SUTURED WITH ONE STITCH. THERE WERE GREY INFLAMMATORY DEPOSITS ON THE INTRAOCULAR LENS (IOL) NOTED AND ANTIBIOTICS WERE GIVEN. THE PT HAD PERIBULBAR ANAESTHESIA. POSTOPERATIVE, THE FOLLOWING TREATMENTS WERE PRESCRIBED: TOBRADEX, INDOCOLLYRE (INDOMETHACIN), MYDRIATICUM (TROPICAMIDE). NO ISSUE OCCURRED DURING SURGERY. ADDITIONAL INFO REC'D STATED THE PT REQUIRED UNPLANNED INTRAVENOUS ANTIBIOTHERAPY, INTRAVITREOUS INJECTION OF ANTIBIOTICS AND CORTICOIDS (SIC) AND LOCAL TREATMENT WITH ANTIBIOTICS, MYDRIATIC AND AN ANTI-INFLAMMATORY TO ADDRESS THE REPORTED EVENT. BACTERIOLOGIC CULTURE AND UNIVERSAL POLYMERASE CHAIN REACTION (PCR) WERE DONE TO THE AQUEOUS SAMPLE AND THE RESULTS WERE NEGATIVE. THE BALANCED SALT SOLUTION, WITH EPINEPHRINE, WAS CHANGED BETWEEN PROCEDURES, ALONG WITH THE IRRIGATION/ASPIRATION TIPS. THE CUSTOM PACK, IOL, AND VISCOELASTICS (TWINVISC) USED BY THE SURGEON WERE NOT ALCON PRODUCTS. THE PT OUTCOME WAS NOTED AS GOOD. ADDITIONAL INFO REC'D STATED THE PT TOTALLY RECOVERED WITHOUT SEQUELAE. THIS REPORT IS FOR ONE PT; FOR ADDITIONAL PT SEE MFG. REPORT # 2028159-2008-00161.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCURUS 200 OPHTHALMIC SURGERY SYSTEM HQC ALCON - IRVINE TECHNOLOGY CENTER ACCURUS 200 NA

Patients

Seq Age Sex Outcome Treatment
1 77 YR Hospitalization| R BSS WITH EPI| CUSTOM PACK| IOL| VISCOELASTICS